Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 billion over the coming years.
While analysts remain optimistic on Adani Ports, they highlight key resistance levels and recommend a wait-and-watch strategy for new investors until a decisive breakout.
